Kelly Ofman Joins AbelsonTaylor Group as VP, Account Director

AbelsonTaylor Group today announced that Kelly Ofman has joined the agency as Vice President, Account Director. Ofman brings more than 15 years of experience leading integrated pharmaceutical marketing initiatives across consumer and healthcare professional (HCP) audiences, with deep expertise in specialty and immunology brands.

Ofman joins AbelsonTaylor Group from Havas Lynx / Havas Life, where she most recently served as Senior Vice President, Management Supervisor. There, she led U.S. and global launch strategy and omnichannel execution for high-profile pharmaceutical brands, including Eisai’s LEQEMBI and Pfizer and Sumitomo’s Myfembree.. Her experience spans the full product lifecycle, from pre-launch strategy through post-launch optimization, with a focus on driving measurable business growth while navigating complex regulatory environments.

Throughout her career, Ofman has played a key role in several major product launches, including leading integrated HCP and DTC efforts for Pfizer’s Comirnaty during multiple FDA indication expansions. She has also developed disease awareness campaigns, clinician education tools, and field enablement resources designed to support diagnosis and treatment adoption across specialty categories.

“Kelly brings a powerful combination of strategic rigor, launch excellence, and deep therapeutic experience,” said Lynnette Hunter, EVP, Director of Client Services at AbelsonTaylor Group. “She understands how to connect insight to execution across audiences and channels, and she has a proven ability to lead teams and clients through some of the most complex and high-stakes moments in a brand’s lifecycle.”

Known for her ability to lead cross-functional teams and drive collaboration across medical, regulatory, and commercial stakeholders, Ofman has overseen multimillion-dollar portfolios and delivered integrated campaigns across digital, print, social, and personal promotion channels. Her work has included developing HCP promotional materials, diagnostic and eligibility tools, advisory board programs, and patient activation campaigns.

In her new role, Ofman will lead multiple client engagements, guiding strategic direction, fostering team development, and driving business growth. She will partner closely with clients to deliver innovative, insight-driven solutions that elevate creative output and deliver measurable impact.

Ofman began her career in pharmaceutical advertising, including earlier roles at Abelson Taylor Group, bringing her experience full circle as she returns to the organization in a senior leadership capacity.

She holds a Bachelor of Arts in Strategic Communication and a Bachelor of Science in Business, Marketing from Miami University.